These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15541261

  • 21. Safety and effectiveness of levosimendan in patients with predominant right heart failure.
    Poelzl G, Zwick RH, Grander W, Metzler B, Jonetzko P, Frick M, Ulmer H, Pachinger O, Roithinger FX.
    Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157
    [Abstract] [Full Text] [Related]

  • 22. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 23. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA, Marsh KC, Polakowski JS, Fryer RM.
    J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
    Mebazaa A, Erhardt L.
    Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
    [Abstract] [Full Text] [Related]

  • 27. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
    Tasal A, Erturk M, Uyarel H, Karakurt H, Bacaksiz A, Vatankulu MA, Turfan M, Sonmez O, Erdogan E, Ergelen M.
    J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
    [Abstract] [Full Text] [Related]

  • 28. The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock.
    Memiş D, Inal MT, Sut N.
    J Crit Care; 2012 Jun; 27(3):318.e1-6. PubMed ID: 21855289
    [Abstract] [Full Text] [Related]

  • 29. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
    Baruch L, Patacsil P, Hameed A, Pina I, Loh E.
    Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Weaning difficult-to-wean chronic obstructive pulmonary disease patients: a pilot study comparing initial hemodynamic effects of levosimendan and dobutamine.
    Ouanes-Besbes L, Ouanes I, Dachraoui F, Dimassi S, Mebazaa A, Abroug F.
    J Crit Care; 2011 Feb; 26(1):15-21. PubMed ID: 20381295
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S, Adamopoulos S, Parissis JT, Rassias J, Kostakis G, Iliodromitis E, Degiannis D, Kremastinos DT.
    Int J Cardiol; 2005 Mar 30; 99(3):409-13. PubMed ID: 15771921
    [Abstract] [Full Text] [Related]

  • 34. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Kerbaul F, Rondelet B, Demester JP, Fesler P, Huez S, Naeije R, Brimioulle S.
    Crit Care Med; 2006 Nov 30; 34(11):2814-9. PubMed ID: 16971854
    [Abstract] [Full Text] [Related]

  • 35. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A, Schmelzle T, Simon R.
    Z Kardiol; 1996 Nov 30; 85(11):839-46. PubMed ID: 9064946
    [Abstract] [Full Text] [Related]

  • 36. Levosimendan: a retrospective single-center case series.
    Berry WT, Hewson RW, Langrish CJ, McKenzie CA, Barrett NA.
    J Crit Care; 2013 Dec 30; 28(6):1075-8. PubMed ID: 23998721
    [Abstract] [Full Text] [Related]

  • 37. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.
    J Card Fail; 2007 Aug 30; 13(6):417-21. PubMed ID: 17675054
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L, Cui L, Wei JP, Li GP, Qi GX, Hao YM, Wang WZ, Li HM, Liu J, Jiang DJ, Zhang YD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun 30; 38(6):527-30. PubMed ID: 21033135
    [Abstract] [Full Text] [Related]

  • 40. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN, Tsagalou EP, Nanas SN, Terrovitis JV, Tsolakis EJ, Toumanidis S, Papazoglou PD, Alexopoulos GP, Kanakakis J, Anastasiou-Nana MI.
    Int J Cardiol; 2006 Apr 04; 108(2):237-43. PubMed ID: 16183152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.